In 3498 adults aged ≥40 having abdominal or thoracic surgery, sugammadex vs neostigmine reversal modestly cut postoperative pulmonary complications or death (19·0% vs 21·5%; RR 0·88, 95% CI 0·77–1·00), driven mainly by atelectasis; pneumonia was similar.
RCTn = 3,498
Leslie et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial